NCT07582523Enrolling by invitation
Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if screening for atrial fibrillation (AFib), a common irregular heart rhythm, through daily home blood pressure monitoring will decrease the time to atrial fibrillation diagnosis in older adults with hypertension. The main question it aims to answer is: \-- Does introducing screening for AFib using a blood pressure monitor with AFib detection technology decrease time to AFib diagnosis in patients with high blood pressure, compared to usual care using a conventional home blood pressure monitor with no AFib detection? Participants will participate in two phases of the study: (1) clinical trial and (2) the registry. During the 6-month clinical trial period, participants will be asked to: * Take blood pressure measurements twice daily * Answer short weekly mobile app-based surveys * If assigned, complete continuous heart monitoring for 2 weeks and complete 1 blood test During the 12-month registry period, participants will be asked to: * Take blood pressure measurements twice daily * Answer monthly mobile app-based surveys Researchers will compare standard blood pressure measurements and AFib screening blood pressure measurements to see if there is a difference in the time to AFib diagnosis and other cardiovascular events. Participants will participate in two phases of the study: (1) trial and (2) the registry. During the 6-month trial period, participants will be asked to: * Take daily blood pressure measurements * Answer short weekly mobile app-based surveys * If assigned, complete continuous heart monitoring for 2 weeks and complete 1 blood test During the 12-month registry period, participants will be asked to: * Take daily blood pressure measurements * Answer monthly mobile app-based surveys
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 1910 (estimated)
- First submitted
- 4 May 2026
- Start date
- 1 Apr 2026
- Primary completion date
- Apr 2029
- Lead sponsor
- University of California, San Francisco
- Diseases
- Atrial fibrillation, High blood pressure
- NCT number
- NCT07582523
What you commit to
- Study type: Interventional
- Planned participants: 1910
- From 1 Apr 2026 to the primary completion date, Apr 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior diagnosis of atrial fibrillation (AFib), atrial flutter, or atrial tachycardia
- Receiving anticoagulation therapy
- Individuals who are currently using home medical devices or wearable devices capable of detecting atrial fibrillation and are unwilling to refrain from using such AF detection device features during the randomized controlled trial (RCT) phase of the study
Other illness
- History of skin allergies to adhesive patches
Other
- Open wound or skin inflammation, such as eczema, in the chest region.
- Inability to wear the patch ECG monitor or apply the monitor by herself/himself or with the help of a caregiver
- People who have a mailing address in Alaska, Hawaii, or a U.S. territory
Who the study is looking for
- Hypertensive\* patients aged 60 years or older living in the United States who meet at least one of the following criteria:
- ≥70 years old
- BMI ≥30kg/m2
- CHA2DS2-VASc ≥3 (excluding Female sex)
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCSF Medical Center at Parnassus Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.